AI-Powered Blood Test for Early Cancer Detection to be Trialed in UK's NHS

Revolutionary AI Blood Test for Cancer Detection

A groundbreaking artificial intelligence-powered blood test, capable of detecting 12 common cancers with over 99% accuracy, is set to undergo trials in the UK's National Health Service (NHS). The test, named miONCO-Dx, was developed by scientists at the University of Southampton in collaboration with biotech startup Xgenera 1

1

2

2

.

How the Test Works

The miONCO-Dx test analyzes microRNA expression in blood samples to detect cancer at an early stage. Using AI, it can identify the presence and origin of the disease 1

1

. The test requires only 10-15 drops of blood and can detect cancer across all stages of tumor growth 3

3

.

Cancers Detected

The test can identify 12 of the most common and lethal cancers, including:

1. Lung
2. Breast
3. Prostate
4. Pancreatic
5. Colorectal
6. Ovarian
7. Liver
8. Brain
9. Esophageal
10. Bladder
11. Bone and soft tissue sarcoma
12. Gastric cancer 1

    1

    3

    3

Trial and Funding

The Department of Health and Social Care (DHSC) has awarded Xgenera £2.4 million to advance the development of the test 1

1

. A clinical trial involving 8,000 patients will be conducted by the Cancer Research UK Southampton Clinical Trials Unit 1

1

4

4

. This trial follows initial analysis of data from more than 20,000 patients, which showed the test's high accuracy in early-stage cancer detection 1

1

.

Potential Impact on Cancer Screening

Dr. Victoria Goss, head of early diagnosis and translational research at the trials unit, stated, "A reliable test such as this could have the potential to see a major shift in cancer screening, making it easier and cheaper to provide on the NHS, cutting health inequalities, and ultimately reducing the number of people who die from the disease" 1

1

.

Comparison to Existing Methods

Currently, the UK only offers screening for three types of cancer, with each test targeting a single type 1

1

. The miONCO-Dx test could potentially replace more invasive procedures such as biopsies and colonoscopies, saving both lives and money 3

3

.

Government Support and Future Prospects

Health Secretary Wes Streeting emphasized the importance of early cancer detection, stating, "The key to surviving cancer is catching it as early as possible, so this government is taking the urgent action needed to make sure that happens" 1

1

. If successful, the test could be expanded to detect over 50 other cancers in the future 1

1

.

Bowelbabe Laboratory

The announcement of the trial coincided with the renaming of a laboratory in memory of Dame Deborah James, a bowel cancer campaigner who passed away at the age of 40 4

4

. The Bowelbabe Laboratory, funded by Cancer Research UK, will bring together leading scientists to advance understanding of bowel cancer and develop new tests and treatments 3

3

4

4

.

This innovative AI-powered blood test represents a significant step forward in early cancer detection and could potentially revolutionize cancer screening practices in the UK and beyond.